XNPT:
Analysis & Opinions
-
October 12, 2012
On a bad day for the market, the Nasdaq has declined 0.2%, the S&P 500 has slipped 0.4% and the Dow has fallen 0.2%. ...
-
July 12, 2012
XenoPort, Inc. (XNPT) and Astellas Pharma Inc. recently announced the launch of Regnite extended-release tablets in ...
-
June 12, 2012
GlaxoSmithKline plc (GSK) and XenoPort, Inc. (XNPT) recently announced that their drug, Horizant, has been approved ...
-
April 11, 2011
Xenoport's pipeline is thin, but Horizant approval buys valuable time.
-
March 03, 2011
Salix has taken another blow from the FDA, but seems too cheap given its prospects.
-
February 23, 2010
The biotech sector lagged the market in 2009, but it is off to a great start in 2010.
